Profil
Shawn Pieter van Boheemen is Secretary & Executive Director at Phoslock Environmental Technologies Ltd. since 2024.
Mr. van Boheemen is CFO, Secretary & Non-Executive Director at Audio Pixels Holdings Ltd. since 2023.
Mr. van Boheemen is Chief Financial Officer & Secretary at Noxopharm Ltd. since 2019.
Former roles include Chief Financial Officer at Nyrada, Inc. Education includes undergraduate and graduate degrees from the University of The West of Scotland.
Postes actifs de Shawn van Boheemen
| Sociétés | Poste | Début |
|---|---|---|
| NOXOPHARM LIMITED | Directeur Financier/CFO | 01/03/2019 |
| PHOSLOCK ENVIRONMENTAL TECHNOLOGIES LIMITED | Directeur/Membre du Conseil | 18/01/2024 |
| AUDIO PIXELS HOLDINGS LIMITED | Directeur Financier/CFO | 31/07/2023 |
Anciens postes connus de Shawn van Boheemen
| Sociétés | Poste | Fin |
|---|---|---|
| NYRADA INC. | Directeur Financier/CFO | 21/04/2020 |
Formation de Shawn van Boheemen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Phoslock Environmental Technologies Ltd.
Phoslock Environmental Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in marketing and commercialization of a water treatment technology | Commercial Services |
Audio Pixels Holdings Ltd.
Audio Pixels Holdings Ltd. Electronics/AppliancesConsumer Durables Develops and markets digital speakers and consumer electronic devices | Consumer Durables |
University of The West of Scotland
University of The West of Scotland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Noxopharm Ltd.
Noxopharm Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
Nyrada, Inc.
Nyrada, Inc. Pharmaceuticals: MajorHealth Technology Operates as pre-clinical stage drug development company, specializes in development of novel small molecule drugs | Health Technology |
















